Home Analyst Ratings Endeavour Silver gets its Buy rating reiterated by HC Wainwright &...

Endeavour Silver [EXK] gets its Buy rating reiterated by HC Wainwright & Co.

HC Wainwright & Co. maintained its Endeavour Silver [EXK] rating to the equivalent of Buy but changed the price target to $6.75 from $5.75, in a research note dated 2021-01-08. That figure represents around a 25.29% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with B. Riley FBR’s analysts assigning the shares to “a Buy” rating in a research note to investors issued in late July. Meanwhile, Noble Capital Markets had lowered its rating on EXK to “Market perform” from the earlier “an Outperform”, in a research note produced for clients February 26, 2020. In addition, there was no change from H.C. Wainwright on November 22, 2019. The rater maintained EXK to “a Buy” but assigned new target price of $3.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Endeavour Silver Corp. [NYSE:EXK] a Good Buy Right Now?

It should be noted that EXK technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 88% Buy in the last week and compares with 72% Buy in the past month. Data from Endeavour Silver Corp.’s Trend Spotter indicated that the signals were Weakest. The stock current average is 3.92 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 2.99 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 3.18 million shares.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

EXK Price Performance

On Wall Street, Endeavour Silver Corp. [NYSE:EXK] finished Thursday’s session down -4.10% at $5.38. The stock went up to $5.71 at the same session while its lowest single day price was $5.25. In the last five days, it saw a rise of about 6.32%, Endeavour Silver Corp. shares gained by almost 6.75% since the beginning of the year. However, the share price has dropped to as low as -8.03% below its one year high. On 01/04/21, the company shares recorded $5.85, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/07/21, the same year at $5.25. The company’s shares have inclined by 145.66% in the past year. The 50-day SMA achieved is $3.92 while the 200-day SMA is $3.06. Volume dropped to 4.16 million from 5.88 million in the previous session.

EXK Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 5.18 level, and in case of violation of this particular level, it will cause more drop to 4.99 level. On the upper level, 5.91 is still the key resistance. The stock may increase to the subsequent resistance at 5.64. The Relative Strength Index (RSI) pinned on the 14-day chart is 68.12, implying a neutral technical stance while the MACD stands at 0.65, meaning price will decrease in the next trading period. Percent R indicator moved to 27.98%, implying bullish price movement. Stochastic %K at 84.67% suggest selling the stock.

What is the short interest in Endeavour Silver Corp.?

Short interest in the Endeavour Silver Corp. stock has plunged, decreasing by -0.95 million shares to total 4.62 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 3.67 million, data from Yahoo Finance shows. The increase of 20.56% suggests the stock saw some increased bearish sentiment.

Endeavour Silver Corp.’s Biggest Shareholders: Who Owns Endeavour Silver Corp. [EXK]?

Filings by Van Eck Associates Corp. showed that the firm now holds a total of 8,341,841 shares or roughly 5.30% of the outstanding EXK shares. This means their shares have increased by 1,181,174 from the 8,341,841 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, Global X Management Co. LLC updated stake is worth $11,818,859. The ETF Managers Group LLC’s holdings currently number 2,508,135 shares at $13493766.3. According to the firm’s last 13F report, Renaissance Technologies LLC shares in the company at filing stood at 1,258,938 shares, roughly $4,292,979.

EXK Earnings Forecast For The Current Quarter

Endeavour Silver Corp. [EXK] is expected to report weak earnings results for the quarter ending on Mar 2018. Consensus estimates give the company expected revenues of $38.33M and an earnings per share of $0.04 for Mar 2018. Looking further ahead, the company is expected to report revenue of $40.1M at an EPS of $0.05 for Jun 2018. The estimates represent upside of 6.60% and 0.00% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

EXK Earnings Estimates For The Current Year

For the financial year, Endeavour Silver Corp. [NYSE:EXK] is expected to bring in revenue of $174.28M. The returns are nearly $23.78 million higher than the company’s actual revenue recorded in the fiscal year 2017. In terms of EPS for the 2018, estimate put it at 0.19, higher than that of FY17 by $0.11. Estimates put this year’s earnings growth at 137.50%. As for sales, forecasts are for an increase of 15.80% in the current fiscal year and a further 6.60% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Here is why Sanderson Farms Inc. (SAFM) stock rallied on Monday?

Sanderson Farms Inc. (SAFM) shares surged 10.16% in after-hours on Monday, June 21, 2021, and close the day at $183.50 per share. Earlier in...

Pyxis Tankers Inc. (PXS) stock fell during pre-market trading. Why so?

Pyxis Tankers Inc. (NASDAQ: PXS) stock declined by 0.06% at the last close while the PXS stock price plunged by 6.15% in the pre-market...

Why STAAR Surgical Company (STAA) stock went up on Tuesday?

STAAR Surgical Company (STAA) shares rose 5.84% in after-hours on Tuesday, June 22, 2021, and closed the day at $151.25 per share. earlier in...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam